Zentek (CVE:ZEN) Trading 41.8% Higher - Time to Buy?

Key Points

• Zentek Ltd. shares surged by 41.8% during mid-day trading, reaching a price of C$1.29 after previously closing at C$0.91.
• The company has a market capitalization of C$135.08 million and a significantly high debt-to-equity ratio of 4.97.
• Zentek focuses on the research and development of graphene and related nanomaterials, producing products such as antimicrobial coatings and personal protective equipment.

Zentek Ltd. (CVE:ZEN - ) shares traded up 41.8% during mid-day trading on Tuesday . The company traded as high as C$1.70 and last traded at C$1.29. 407,343 shares changed hands during trading, an increase of 752% from the average session volume of 47,792 shares. The stock had previously closed at C$0.91.

Zentek Stock Performance

The company has a debt-to-equity ratio of 4.97, a quick ratio of 7.59 and a current ratio of 2.06. The business's fifty day simple moving average is C$1.24 and its 200-day simple moving average is C$1.58. The firm has a market capitalization of C$135.08 million, a PE ratio of -16.13 and a beta of 0.57.

Zentek Company Profile

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.